TOUCH BIONICS LIMITEDActive
Key figures
Ratios
2020Balance sheet structure
Filed accounts2020
| 2020 | |
|---|---|
| Turnover | 10,759,201 |
| Cash at bank and in hand | 1,228,427 |
| Total assets | 29,024,212 |
| Total liabilities | 3,849,610 |
| Net assets / total equity | 24,995,906 |
| Average number of employees | 45 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2020The principal activity of the company is the design, manufacture and sale of medical equipment (artificial upperlimb components).The company’s key measurement of effectiveness is sales growth and profitability. The directors consider that thebusiness will remain profitable for the foreseeable future and strategies are in place to increase sales growth.There has been a significant decline in turnover by £6 million that is 36% during the year and the profit has alsoreduced by £3.6 million. This was mainly due to the effect of COVID-19 as some of the markets were in lock downfor some part of the current year.
As described in the company's latest filed accounts.
Summary: TOUCH BIONICS LIMITED
Company
TOUCH BIONICS LIMITED is a private limited company registered with Companies House under company number SC232512. It was incorporated on 7 Jun 2002. Its status is active. The registered office is in Livingston (EH54). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500).
Accounts
The latest accounts in the database are for 2020 (period ending 31 Dec 2020); the company files full accounts. Turnover was £10,759,201. Net assets were £24,995,906. Cash at bank and in hand was £1,228,427. Total assets were £29,024,212 and total liabilities £3,849,610. The company had an average of 45 employees.
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 14 Jul 2027.